Raia Drogasil (BSP:RADL3) Selling and Marketing Expense : R$6,896 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Raia Drogasil's Selling and Marketing Expense for the three months ended in Mar. 2024 was R$1,768 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was R$6,896 Mil.

Raia Drogasil Selling and Marketing Expense Historical Data

The historical data trend for Raia Drogasil's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Selling and Marketing Expense Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Selling and Marketing Expense

Get a 7-Day Free Trial

3,754.77

4,256.42

4,966.82

5,805.99

6,689.28

Raia Drogasil Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Selling and Marketing Expense	Get a 7-Day Free Trial															1,560.77	1,622.85	1,713.05	1,792.61	1,767.97

Raia Drogasil Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$6,896 Mil.

Raia Drogasil Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (BSP:RADL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

RADLY:USA

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines